Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Air Displacement Pipettors Empower a New Line of Microbiology Diagnostic Instruments

By BiotechDaily International staff writers
Posted on 23 Dec 2013
Image: The new Cavro Air Displacement Pipettor (ADP) is a compact, pneumatic pipetting solution for easy integration and exceptional liquid handling performance (Photo courtesy of Tecan).
Image: The new Cavro Air Displacement Pipettor (ADP) is a compact, pneumatic pipetting solution for easy integration and exceptional liquid handling performance (Photo courtesy of Tecan).
Image: Cavro ADP modules in the PRELUD instrument enables accurate liquid dispensing ranging from microliters to milliliters (Photo courtesy of Tecan).
Image: Cavro ADP modules in the PRELUD instrument enables accurate liquid dispensing ranging from microliters to milliliters (Photo courtesy of Tecan).
A French manufacturer of microbiology diagnostic instruments had incorporated Swiss-built air displaced pipette units in its new line of liquid handling systems.

Tecan (Männedorf, Switzerland), a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics recently announced that the French microbiological instrument manufacturer i2a (Montpellier, France) would be incorporating its Cavro Air Displacement Pipettor (ADP) into PRELUD, an automated preanalytical instrument for the inoculation of culture plates and preparation of agar susceptibility tests.

The Cavro ADP is a fully programmable pneumatic pipetting module that uses air rather than liquid displacement to aspirate and dispense fluids. The slender design allows the Cavro ADP to be mounted in automated applications with narrow 18 mm spacing between devices. The Cavro ADP is compatible with Tecan’s high quality disposable tips (DiTis) for situations where washing tips between samples is ineffective or impractical.

“We needed something very light and easy to use, and that was capable of pipetting liquid volumes ranging from microliters to milliliters,” said Michel Roch, i2a's PRELUD project manager. “The Cavro ADP was easy to integrate because it operates mechanically without the use of liquids, and it allows precision liquid dispensing. The tip ejector was another highly useful function; we use Tecan’s disposable tips and simply change between 10 microliter, 200 microliter and 1 milliliter tips according to our needs. We were able to integrate the Cavro ADP into PRELUD very quickly and, within two days, we could handle liquids. The reproducibility, precision, and accuracy of the Cavro ADP are good enough for our microbiology application without the need for any further tests or trials. We are very satisfied with our collaboration with Tecan.”

Related Links:
Tecan
i2a 


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.